Clinical Trials Logo

Pyridoxine Dependant Epilepsy clinical trials

View clinical trials related to Pyridoxine Dependant Epilepsy.

Filter by:
  • None
  • Page 1

NCT ID: NCT04672226 Completed - Clinical trials for Pyridoxine Dependant Epilepsy

Evaluation of PDE MAX

PDE MAX
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

PDE MAX is a single arm prospective, feasibility study in up to 15 participants aged one (1) year and over of PDE MAX for the dietary management of Pyridoxine Dependent Epilepsy.

NCT ID: NCT01795170 Withdrawn - Clinical trials for Pyridoxine Dependant Epilepsy

Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine Dependent Epilepsy Patients

NOEL
Start date: April 2013
Phase: N/A
Study type: Observational

Restricting dietary lysine intake in infants from age 3 months or less with confirmed diagnosis of pyridoxine-dependent epilepsy due to Antiquitin (ATQ) deficiency will: reduce the accumulation of neurotoxic substratesα-aminoadipicsemialdehydeandits cyclic equivalent 1-piperideine-6-carboxylate;and will improve overall neurodevelopmental outcome at 3 years of age by acting as an effective intervention into the complex pathophysiology of the condition.